-
ASAM Weekly for October 25, 2022
Full story -
ASAM Holds Second Annual State Advocacy Summit
On October 14th, ASAM held its second annual virtual State Advocacy Summit for state chapter members. This three-hour, members-only event was divided into five main sessions and included ASAM members from 33 states, who represent 32 of ASAM’s state chapters.Full story -
ASAM Weekly for October 18, 2022
Full story -
National Addiction Treatment Week Highlights Rewarding Career
Specialists share inspiring stories urging the medical community to treat addiction and save livesFull story -
ASAM Releases Public Policy Statements on Optimizing Telehealth Access to Addiction Care; Substance Use and Substance Use Disorder Among Pregnant and Postpartum People
ASAM has released two new public policy statements with recommendations for improving addiction care in the United States. The first, “Optimizing Telehealth Access to Addiction Care,” focuses on the role of telehealth in treating addiction. The second, “Substance Use and Substance Use Disorder Among Pregnant and Postpartum People,” includes policy recommendations for improving health outcomes for pregnant and postpartum people who use substances or have substance use disorder (SUD).Full story -
ASAM Weekly for October 11, 2022
Full story -
ASAM Weekly for October 4, 2022
Full story -
Public Comment Period Opens for Updates to Addiction Treatment Standards
New Edition of “The ASAM Criteria” to be published by Hazelden Publishing. A book of standards at the center of America’s addiction treatment ecosystem will soon be updated and enhanced to facilitate better care for the millions of people diagnosed with substance use disorders each year.Full story -
ASAM Statement on the U.S. Congress Joint Economic Committee’s New Report on the Economic Toll of the Opioid Crisis
Full story -
ASAM Requests Legislative Clarifications in U.S. House Ways and Means Committee Legislation to Expand Access to Mental Health and SUD Care Under Medicare
On September 28th, ASAM wrote to the Chair Richard Neal and Ranking Member Kevin Brady of the U.S. House Ways and Means Committee.Full story -
ASAM Weekly for September 27, 2022
Full story -
ASAM Applauds Biden Administration for Making Major Investments in Addiction Care and Facilitating Greater Naloxone Access
Full story -
PSAM Opposes Prior Authorization on Evidence-Based Addiction Treatment
Full story -
ASAM Weekly for September 20, 2022
Full story -
ASAM Joins Letter to FDA Supporting Reduced Nicotine in Cigarettes
ASAM joined a coalition of public health, medical, and professional organizations in a letter to the Food and Drug Administration (FDA), supporting its intention to issue a proposed rule to reduce the nicotine level in cigarettes to non-addictive or minimally addictive levels.Full story -
LSAM Shares Kratom Policy Recommendations with Louisiana Lawmakers
The Louisiana Society of Addiction Medicine (LSAM) sent a letter to the leadership of the Health and Welfare Committees in both the Louisiana House and Senate outlining its position on kratom policy.Full story -
ASAM Submits Comments to CMS on Medicare Physician Fee Schedule
On September 6, ASAM submitted comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed 2023 Medicare Physician Fee Schedule (MPFS).Full story -
ASAM Joins Letter to CMS on Conditions of Participation for Rural Emergency Hospitals
ASAM joined others in a letter to the Centers for Medicare and Medicaid Services (CMS), recommending that CMS increase access to evidence-based treatment at Rural Emergency Hospitals.Full story -
LSAM Urges Caution in Further Expansion of Louisiana’s Medical Cannabis Program
Full story -
ASAM Urges CMS to Implement Changes to Ensure Equitable, High Quality, and Whole-Person Addiction Care that is Affordable and Sustainable in the Medicare Advantage Program
On August 23, ASAM submitted comments responding to Centers for Medicare and Medicaid Services’ (CMS) request for information on the Medicare Advantage (MA) program, requesting CMS strengthen network adequacy requirements to further support enrollee access to addiction care, and ensure health plans’ utilization management does not adversely affect enrollees’ access to medically necessary addiction care.Full story